Billion to One

Our genome is made up of three billion nucleotides, which can be a challenge when it comes to detecting and quantifying diseases. With the help of Billion to One's proprietary technology, however, this is now achievable. Focused on various disease states, their unique technology has the ability to detect and quantify disease at single base-pair resolution. My role with Billion to One was to develop print and digital templates based on their existing brand guidelines.